BCLSI

Bain Capital Life Sciences Investors Portfolio holdings

AUM $799M
This Quarter Return
+9.62%
1 Year Return
+36.47%
3 Year Return
+278.05%
5 Year Return
+363.53%
10 Year Return
–
AUM
$838M
AUM Growth
+$838M
Cap. Flow
-$60.9M
Cap. Flow %
-7.27%
Top 10 Hldgs %
68.16%
Holding
36
New
1
Increased
3
Reduced
3
Closed
3

Top Buys

1
THRD
Third Harmonic Bio
THRD
$43.3M
2
XFOR icon
X4 Pharmaceuticals
XFOR
$5.76M
3
ANNX icon
Annexon
ANNX
$2.23M
4
ACAD icon
Acadia Pharmaceuticals
ACAD
$164K

Top Sells

1
SYRS
Syros Pharmaceuticals, Inc. Common Stock
SYRS
$33.4M
2
DVAX icon
Dynavax Technologies
DVAX
$31.3M
3
AMLX icon
Amylyx Pharmaceuticals
AMLX
$26M
4
RACB
Research Alliance Corp. II Class A Common Stock
RACB
$9.8M
5
ARYD
ARYA Sciences Acquisition Corp IV Class A Odinary Shares
ARYD
$6.87M

Sector Composition

1 Healthcare 97.33%
2 Financials 1.17%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
SWTX
1
DELISTED
SpringWorks Therapeutics
SWTX
$138M 16.45% 4,831,307 – –
NUVL icon
2
Nuvalent
NUVL
$5.52B
$66.6M 7.95% 3,428,014 – –
MRSN icon
3
Mersana Therapeutics
MRSN
$36.5M
$58.6M 6.99% 8,663,673 – –
ARQT icon
4
Arcutis Biotherapeutics
ARQT
$1.86B
$57.3M 6.84% 3,000,000 – –
DVAX icon
5
Dynavax Technologies
DVAX
$1.19B
$56.5M 6.75% 5,415,000 -3,000,000 -36% -$31.3M
EQRX
6
DELISTED
EQRx, Inc. Common Stock
EQRX
$49.5M 5.91% 10,003,573 – –
CRNX icon
7
Crinetics Pharmaceuticals
CRNX
$2.92B
$45.3M 5.41% 2,305,558 – –
THRD
8
DELISTED
Third Harmonic Bio
THRD
$43.3M 5.16% +2,280,082 New +$43.3M
AMLX icon
9
Amylyx Pharmaceuticals
AMLX
$836M
$28.8M 3.44% 1,023,214 -925,000 -47% -$26M
RPID icon
10
Rapid Micro Biosystems
RPID
$107M
$27.2M 3.25% 8,434,560 – –
TVRD
11
Tvardi Therapeutics, Inc. Common Stock
TVRD
$281M
$24.8M 2.96% 2,647,473 – –
PHVS icon
12
Pharvaris
PHVS
$1.39B
$24.4M 2.91% 3,180,601 – –
NRIX icon
13
Nurix Therapeutics
NRIX
$714M
$23.8M 2.84% 1,822,883 – –
ANNX icon
14
Annexon
ANNX
$226M
$22.3M 2.66% 3,601,926 +360,298 +11% +$2.23M
TSVT
15
DELISTED
2seventy bio
TSVT
$20.5M 2.45% 1,408,901 – –
PTGX icon
16
Protagonist Therapeutics
PTGX
$3.67B
$19.1M 2.27% 2,260,572 – –
SVRA icon
17
Savara
SVRA
$567M
$18M 2.15% 11,622,598 – –
CCCC icon
18
C4 Therapeutics
CCCC
$185M
$14.4M 1.72% 1,642,210 – –
AVIR icon
19
Atea Pharmaceuticals
AVIR
$267M
$14.1M 1.69% 2,485,638 – –
XFOR icon
20
X4 Pharmaceuticals
XFOR
$84.2M
$10.9M 1.3% 6,389,436 +3,369,896 +112% +$5.76M
ACAD icon
21
Acadia Pharmaceuticals
ACAD
$4.38B
$9.99M 1.19% 610,523 +10,000 +2% +$164K
MRNS
22
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
$9.52M 1.14% 1,431,058 – –
XLO icon
23
Xilio Therapeutics
XLO
$36.3M
$8.16M 0.97% 2,805,413 – –
SYRS
24
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
$6.97M 0.83% 1,082,404 -5,182,016 -83% -$33.4M
TNGX icon
25
Tango Therapeutics
TNGX
$747M
$6.96M 0.83% 1,921,790 – –
1
2